Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus

Lupus

Volumn 22, Issue 6, 2013, Pages 607-613

  Caneparo, V ^a,b   Cena, T ^a,c   De Andrea, M ^a,d   Dell'Oste, V ^b,d   Stratta, P ^a,c   Quaglia, M ^a,c   Tincani, A ^e,f   Andreoli, L ^e,f   Ceffa, S ^e,f   Taraborelli, M ^e,f   Magnani, C ^a,c,g   Landolfo, S ^b,d   Gariglio, M ^a,b,g  

^a Amedeo Avogadro University   (Italy)

^b NoToPharm Srl ^*  (Italy)

^c Intensive Care Unit Maggiore della Carità University Hospital   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f Rheumatology and Clinical Immunology Unit   (Italy)

^g UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

autoantibodies; IFI16; interferons; proteinuria; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; AUTOANTIBODY; IFI16 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMAN; HYPOCOMPLEMENTEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; IFI16; INTERFERONS; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; COMPLEMENT C3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROTEINURIA;

EID: 84878343386     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313484978     Document Type: Article

References (19)

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011 ; 365: 2110-2121
2. Rekvig OP, Putterman C, Casu C, et al. Autoantibodies in lupus: Culprits or passive bystanders?. Autoimmun Rev. 2012 ; 11: 596-603
3. Mosca M, Tani C, Aringer M, et al. Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice. Autoimmun Rev. 2011 ; 10: 383-388
4. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Sem Arth Rheum. 2004 ; 34: 501-537
5. Schieberck H, Lundbäck P, Palmblad K, et al. Monoclonal anti-HMGB1 antibody protection in two experimental arthritis models. Mol Med. 2011 ; 17: 1039-1044
6. Pisetsky DS. Antinuclear antibodies in rheumatic disease: A proposal for a function-based classification. Scand J Immunol. 2012 ; 76: 223-228
7. Sozzani S, Bosisio D, Scarsi M, Tincani A. Type I interferons in systemic autoimmunity. Autoimmunity. 2010 ; 43: 196-203
8. Gariglio M, Mondini M, De Andrea M, Landolfo S. The multifaceted interferon-inducible p200 family proteins: From cell biology to human pathology. J Interferon Cytokine Res. 2011 ; 31: 159-172
9. Mondini M, Costa S, Sponza S, Gugliesi F, Gariglio M, Landolfo S. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: Implication for autoimmunity. Autoimmunity. 2010 ; 43: 226-231
10. Rozzo SJ, Allard JD, Choubey D, et al. Evidence for interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 2001 ; 15: 435-443
11. Caposio P, Gugliesi F, Zannetti C, et al. A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J Biol Chem. 2007 ; 282: 33515-33529
12. Gugliesi F, De Andrea M, Mondini M, et al. The proapoptotic activity of the interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. J Autoimmun. 2010 ; 35: 114-123
13. Mondini M, Vidali M, Airo P, et al. Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders. Ann N Y Acad Sci. 2007 ; 1110: 47-56
14. Mondini M, Vidali M, De Andrea M, et al. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon-inducible gene IFI16. Arthritis Rheum. 2006 ; 54: 3939-3944
15. Costa S, Borgogna C, Mondini M, et al. Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br J Dermatol. 2011 ; 164: 282-290
16. Costa S, Mondini M, Caneparo V, et al. Detection of anti-IFI16 antibodies by ELISA: Clinical and serological associations in systemic sclerosis. Rheumatology (Oxford). 2011 ; 50: 674-681
17. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med. 2006 ; 354: 2473-2483
18. Viswanathan G, Upadhyay A. Assessment of proteinuria. Adv Chronic Kidney Dis. 2011 ; 18: 243-248
19. Borchers AT, Leibushor L, Naguwa SM, Cheema GS, Shoenfeld Y, Gershwin ME. Lupus nephritis: A critical review. Autoimmunity Rev. 2012 ; 12: 174-194